Despite several steps forward in the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), however there are still pending issues and upcoming challenges requiring adequate addressing in order to optimize the clinical management of metastatic patients harboring molecular alterations within the EGFR gene. This review aims to summarize the most recent findings regarding the diagnostic testing and therapeutic strategies of EGFR-mutant advanced NSCLC.
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review
Passiglia, Francesco;Bironzo, Paolo;Bertaglia, Valentina;Listì, Angela;Garbo, Edoardo;Scagliotti, Giorgio Vittorio
2022-01-01
Abstract
Despite several steps forward in the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), however there are still pending issues and upcoming challenges requiring adequate addressing in order to optimize the clinical management of metastatic patients harboring molecular alterations within the EGFR gene. This review aims to summarize the most recent findings regarding the diagnostic testing and therapeutic strategies of EGFR-mutant advanced NSCLC.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
64084-PB5-6216-R4.pdf
Accesso aperto
Dimensione
403.34 kB
Formato
Adobe PDF
|
403.34 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
